Corbus Pharmaceuticals (CRBP) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-2.16
-1.71
-1.27
-0.83

Details

Expected EPS
-0.951937
Actual EPS
-1.15
Surprise EPS
-0.2
Surprise Percent
-20.81%

Description

⁨Corbus Pharmaceuticals⁩ (⁦CRBP⁩) has reported earnings of ⁦-1.15⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts